Genotyping and outcomes of presumptive second line ART failure cases switched to third line or maintained on second line ART in Mumbai, India.

Naresh GillRafael Van den BerghKhine Wut Yee KyawChinmay LaxmeshwarMrinalini DasSarthak RastogiMiriam Arago GalindoHoma MansoorStobdan KalonPetros Isaakidis

Published in: PloS one (2019)

Adopting WHO guidelines on switching ART regimens and provision of EAC can prevent unnecessary switching/exposure to third-line ART regimens. Genotyping is urgently required in national HIV programs, which currently use only the exposure history of patients for switching to third-line ART regimens.

Keyphrases

hiv infected
antiretroviral therapy
hiv positive
human immunodeficiency virus
end stage renal disease
newly diagnosed
high throughput
hiv aids
ejection fraction
genome wide
hepatitis c virus
palliative care
prognostic factors
metabolic syndrome
quality improvement
patient reported outcomes
south africa